© #oc15europe 1 electronically collecting data from participants in clinical trials june 1, 2015...

41
© #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann [email protected] m

Upload: rosaline-parker

Post on 25-Dec-2015

215 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 1

Electronically Collecting Data from Participants in Clinical Trials

June 1, 2015Ben Baumann

[email protected]

Page 2: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 2

Trajectory Terminology Benefits & Promises Barriers & Reality Technology Regulatory Content Data Management

Page 3: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 3

Page 4: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 4

eCOA(electronic clinical outcomes assessment)

Patient Driven eData

Definition: an electronic assessment that may be influenced by human choices, judgment, or motivation and may support either direct or indirect evidence of treatment benefit.

Assessment = instrument = questionnaire = form…

Page 5: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 5

eCOA ModalitiesModality Definition Use When Examples

ePRO (Patient-reported outcomes)

Data reported electronically directly verbatim by subjects. Self report, or interview.

• Trained health professional not needed + self-report feasible and appropriate.

• Unobservable concepts (feelings, sensations)

• Pain intensity• Mood/feelings• Eating habits

ClinRO (Clinician-reported outcome)

Report from a health-care professional observing subject’s condition. Involves clinical judgement/interpretation.

Trained health professional needed

• tumor size• Parkinson’s patient who

cannot comment• palpating a spleen

ObsRO (Observer-reported outcome)

Measurement based on an observation by someone other than the patient or a health professional. Does not include medical judgment/interpretation.

Trained health professional not needed and self-report NOT feasible/appropriate.

• parent/infant• caregiver/elderly person

PerfO (Performance outcome)

Performance of a task by subject based on instructions administered by a HC professional

The specific task is required by protocol

• 6 minute walk test• Memory recall

Page 6: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 6

Why do it?

Page 7: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 7

• Better dataQuality

• Faster, less laborProductivity

• Engage patients in new ways

Enablement

Page 8: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 8

May Clinic Study

How would you describe your overall quality of life today?

0 1 2 3 4 5 6 7 8 9 10 As bad as can be

As good as can be

Score of 5 or less, 15 months survival Sore of 5+, 52 months survival Cannot ignore decrease of 2

3,704 cancer patients

This is a prognostic factor for cancer patient survival

Page 9: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 9

Incorporated QOL assessment into daily clinical oncology practice

Initiated conversations with patients Insomnia Stupid thoughts

Reduced emergent care

Improved survival

Improved quality of life

Page 10: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 10

Paper vs. ElectronicPaper

Piles of paper can be confusing

Don’t need to worry about the internet

Chance of getting lost/destroyed

Slow access to actionable information

Parking lot syndrome

eCOA More controlled experience

System prompts user automatically

Increased compliance (regulatory, patient) Requires secure login/password

Date/Time Stamped in Audit Trail

E-Source recorded in Audit Trail

Page 11: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 11

Drivers of eCOA Quality & Efficiency

Increased data quality (edit checks, data types, show/hides, required fields)

More efficient data collection (reduce need for data entry)

Improved patient compliance1,2

Auto-reminders Electronically monitor

Know exactly when something happens

Report deviations to sites immediately

Get data earlier to prevent problems

Better patient care

Cost savings

1 ePRO often produces compliance rates over 90%. See Meltzer EO, Kelley N, Hovell MF (2008). "Randomized, Cross-Over Evaluation of Mobile Phone vs Paper Diary in Subjects with Mild to Moderate Persistent Asthma". 2 Friedberg F, Sohl SJ (2008). "Memory for Fatigue in Chronic Fatigue Syndrome: The Relation Between Weekly Recall and Momentary Ratings". International Journal of Behavioral Medicine 15 (1): 29–33

Page 12: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 12

Drivers of eCOA (cont.) Technology trends

Ubiquity of internet access Mobile devices Responsive design Sensory devices Apple ResearchKit

Page 13: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 13

Drivers of eCOA (cont.) Patient engagement

Integrate into subjects’ lives, especially if BYOD Fewer dropouts More events Feedback

Improvement over time Comparison vs. the field

Engaged Patients

Increased Compliance

Page 14: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 14

eCOA in an ALCOA World

Attributable

Legible

Contemporaneous

Original

Accurate

Login / access code

Can control when things happen

It’s digital, structured

ePRO captured directly from subject

Edit checks, rules logic

CompleteConsistentEnduringAvailable

Page 15: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 15

Page 16: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 16

Barriers to Adopting eCOA

Expense (or, at least perceived expense)

Devices / Logistical complexity

Usability

Fit with study population

Integrating with existing EDC/CDM Systems

“Translating” existing PROs to electronic form

Others? What has stopped you?

Page 17: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 17

Adoption of eCOA 2009 FDA PRO guidance1

More trials are collecting COA data

Use of BYOD increasing, but mostly in post-approval studies

Scientific evidence growing to broaden use

Technology farther ahead of the regulations and adoption

1 http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf

Page 18: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 18

Success = Planning + Implementation

So, let’s break it down:

Formula for Success

• Patient experience• Content• Regulations• Technology

Page 19: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 19

Patient Experience

How will you engage your patients? Motivation Incentive Feedback

Page 20: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 20

Usability Number of forms/instruments Items per page Scolling Edit checks Required fields Skip logic Accommodating disabilities Offline Support: patients, devices, logistics

“Simple can be harder than complex: You have to work hard to get your thinking clean to make it simple. But it’s worth it in the end because once you get there, you can move mountains.”

- Steve Jobs

Page 21: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 21

Language

Will instrument be translated? Avoid idiomatic expressions Allowing for text length Left Right, Right Left

pressclickmouse

select

choose

enter

Page 22: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 22

Item Stems & Recall Making questions self contained

During the last week, how has the pain interfered with: Going to work Sleeping at night

During the last week, how has the pain interfered with going to work?

During the last week, how has the pain interfered with sleeping at night?

Page 23: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 23

Usability Testing Field-test involving patients (ePRO) and/or clinicians

(ClinRO) -- use the real thing

Page 24: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 24

Electrifying Existing COAs

1 FDA PRO Guidance 2009: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf

Must show eCOA version yields data which are equivalent or superior to paper version.

eCOA version must measure the same thing as paper

Need to show evidence of evidence of equivalence1

Level of evidence depends on severity of change

Page 25: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 25

Evidence of Equivalence

Table from ISPOR ePRO Task Force Paper: http://www.ispor.org/workpaper/patient_reported_outcomes/Coons.pdf

Page 26: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 26

Content: Leveraging Others’ Work C-Path PRO and ePRO Consortia (www.c-path.org)

Pre-competitive, FDA + industry Collaborate to generate measurement equivalence data Best practices

PROMIS (www.nihpromis.org/) Freely distributes instruments Tested, multiple languages

ISPOR (http://www.ispor.org/)

Page 27: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe

Regulations: Available Guidance

27

Page 28: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 28

2009 FDA PRO GuidanceHow FDA reviews and evaluates existing, modified, or newly created patient-reported outcome (PRO) instruments used to support claims in approved medical product labeling.

Page 29: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 29

Page 30: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 30

2013 FDA E-Source Guidance Assure reliability, quality, integrity, and traceability of data from electronic source

to electronic regulatory submission.

Promotes capturing source data in electronic form

Retention of electronic source data in FDA-regulated clinical investigations.

Page 31: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 31

2013 Mobile Medical Applications

Page 32: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 32

Mobile Medical Applications

Mobile App: A software application that can be run on a mobile platform, or a web-based software application that is tailored to a mobile platform but runs on a server.

Mobile Medical App: A mobile app that meets the definition of a device and is intended: To be used as an accessory to a regulated medical device

To transform a mobile platform into a regulated medical device (e.g., via a sensor or electrode)

FDA intends to apply its regulatory oversight to only those mobile apps that are medical devices and whose functionality could pose a risk to a patient’s safety if the mobile app were to not function as intended.

Page 33: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 33

Technology

Page 34: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 34

Choices, choices…

Web-based

Choice Considerations

Smart Phone • Typically used for ePRO• Well-integrated messaging (SMS, phone, email)• Smaller screens may present issues for certain

instruments• Logistics if provisioning

Tablets • Typically used in ClinRO settings• More readily emulate paper• Logistics if provisioning• Less validation burden

Digital Pen • Special pen, special paper• Still have paper• Legibility• Technology support

IVR • Limited types of questions• Recall time• Patients get frustrated

Page 35: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 35

App vs. Web Limitations and Liberties

Pushing updates

Validation

Data stored on device

Responsive design

What actually is the app?Web?

App?

Page 36: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 36

BYOD?Provide device?

Device Provisioning vs. BYODDevice BYOD

User may forget Already in habit of using

Greater control Unknown device configurations

Connectivity issues Already connected

Simpler validation Device checksResponsive design

Connectivity issues Participate already connected

Lots of logistics and support

Little to none

Hybrid BYOD / Provisioning an option

…or both?

Page 37: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 37

Role of Data Management Edit checks/controls at entry Required fields: complete data vs. accurate data Frequency of data collection EDC/CDMS integration Reviewing data How to handle data received too early / too late Clear policy with sites around changing ePRO data (e.g. visit dates,

basic demographics) Under control of investigator at all times Paper as back-up; how to handle Site Support, FAQ

Page 38: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 38

Putting it All Together

Page 39: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 39

Thinking About ROIPaper

Costs you are incurring: Printing

Mailing

Data Entry

Data Cleaning

Electronic

Costs you are incurring: Electronic system

Costs you are saving: Less data entry

Less data cleaning

Printing and mailing

Fewer site payments

Quality benefits: Increased accuracy

Removing interpretation

More time for patients

Faster study closeout

Vs.

Some estimates as high as $20 per page

Page 40: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe

We Can Do This!Technology has advanced and we have the power to use

that technology to improve patient care.

40

Page 41: © #OC15Europe 1 Electronically Collecting Data from Participants in Clinical Trials June 1, 2015 Ben Baumann bbaumann@openclincia.com

©

#OC15Europe 41

Thank You!

Ben BaumannOpenClinica, LLC

[email protected]